PACIARONI, Maurizio
 Distribuzione geografica
Continente #
AS - Asia 5.867
NA - Nord America 5.023
EU - Europa 3.077
SA - Sud America 1.260
AF - Africa 231
OC - Oceania 40
Totale 15.498
Nazione #
US - Stati Uniti d'America 4.668
SG - Singapore 1.573
BD - Bangladesh 1.447
IT - Italia 1.430
BR - Brasile 942
HK - Hong Kong 693
CN - Cina 680
VN - Vietnam 626
NL - Olanda 351
CA - Canada 213
FR - Francia 199
DE - Germania 195
JP - Giappone 178
GB - Regno Unito 165
IN - India 146
FI - Finlandia 123
AR - Argentina 109
RU - Federazione Russa 93
ZA - Sudafrica 74
UA - Ucraina 71
MX - Messico 70
ES - Italia 69
EC - Ecuador 68
ID - Indonesia 66
BE - Belgio 56
IQ - Iraq 56
AE - Emirati Arabi Uniti 55
PL - Polonia 52
TR - Turchia 51
AT - Austria 47
PK - Pakistan 46
PT - Portogallo 46
EG - Egitto 41
AU - Australia 36
CO - Colombia 36
SE - Svezia 33
HU - Ungheria 32
VE - Venezuela 31
TW - Taiwan 30
IE - Irlanda 28
MA - Marocco 28
MY - Malesia 28
PH - Filippine 27
UZ - Uzbekistan 26
SA - Arabia Saudita 24
CL - Cile 23
PY - Paraguay 21
JM - Giamaica 18
TN - Tunisia 18
PE - Perù 15
KE - Kenya 14
NP - Nepal 14
DZ - Algeria 13
KZ - Kazakistan 13
NO - Norvegia 13
CH - Svizzera 12
ET - Etiopia 12
IL - Israele 11
BO - Bolivia 10
CR - Costa Rica 10
JO - Giordania 10
LT - Lituania 10
AZ - Azerbaigian 9
DO - Repubblica Dominicana 8
NI - Nicaragua 8
OM - Oman 8
CZ - Repubblica Ceca 7
HN - Honduras 7
RO - Romania 7
IR - Iran 6
PA - Panama 6
AM - Armenia 5
GR - Grecia 5
HR - Croazia 5
KG - Kirghizistan 5
NG - Nigeria 5
RS - Serbia 5
TH - Thailandia 5
UY - Uruguay 5
AL - Albania 4
BY - Bielorussia 4
GT - Guatemala 4
KR - Corea 4
LA - Repubblica Popolare Democratica del Laos 4
PS - Palestinian Territory 4
AO - Angola 3
BB - Barbados 3
BG - Bulgaria 3
CG - Congo 3
DK - Danimarca 3
GE - Georgia 3
LV - Lettonia 3
LY - Libia 3
PR - Porto Rico 3
TZ - Tanzania 3
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BN - Brunei Darussalam 2
CD - Congo 2
CI - Costa d'Avorio 2
Totale 15.465
Città #
Singapore 808
San Jose 763
Ashburn 747
Hong Kong 686
New York 466
Los Angeles 228
Dallas 206
Ho Chi Minh City 204
Beijing 185
Tokyo 167
Hanoi 162
Council Bluffs 120
Chicago 114
Buffalo 112
Amsterdam 97
Milan 97
Rome 96
Santa Clara 90
Bologna 89
São Paulo 80
Helsinki 73
Lauterbourg 70
Naples 64
Toronto 57
Utrecht 53
Hefei 48
Orem 48
Warsaw 46
Turin 40
Abu Dhabi 39
Quito 39
Groningen 38
Lisbon 38
Phoenix 38
Lappeenranta 36
Frankfurt am Main 35
Montreal 35
Bari 34
Florence 34
Mexico City 34
Da Nang 33
Denver 32
Poplar 32
Haiphong 31
Nuremberg 31
Budapest 30
Paris 29
Baghdad 28
Barcelona 28
Mulhouse 28
Palermo 28
Boardman 27
Salt Lake City 27
Atlanta 26
De Lier 26
Stockholm 26
Dublin 25
Cairo 24
Belo Horizonte 23
Brooklyn 23
Charlotte 23
Des Moines 23
Dhaka 23
Taichung 23
Vancouver 23
Rio de Janeiro 22
Tashkent 22
Curitiba 21
Johannesburg 21
Boston 20
Pasadena 20
Sydney 20
Houston 19
Hải Dương 19
London 19
Miami 19
Tampa 19
Falkenstein 18
Ferrara 18
San Francisco 18
Seattle 18
Shanghai 18
Brasília 17
Guayaquil 17
Naaldwijk 17
Chennai 16
Hangzhou 16
Jakarta 16
Kuala Lumpur 15
Madrid 15
Munich 15
Caracas 14
Catania 14
Guarulhos 14
Manchester 14
Venice 14
Washington 14
Genoa 13
Lima 13
Moscow 13
Totale 7.686
Nome #
2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) 1.107
Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study 349
Direct Oral Anticoagulants Versus Warfarin in the Treatment of Cerebral Venous Thrombosis (ACTION-CVT): A Multicenter International Study 167
Association Between Migraine and Cervical Artery Dissection The Italian Project on Stroke in Young Adults 157
Early vs Late Anticoagulation in Minor, Moderate, and Major Ischemic Stroke With Atrial Fibrillation: Post Hoc Analysis of the ELAN Randomized Clinical Trial 152
Transient brain ischemic symptoms and the presence of ischemic lesions at neuroimaging – Results from the READAPT study 151
Left Atrial Appendage Occlusion vs Standard of Care After Ischemic Stroke Despite Anticoagulation 147
European Stroke Organisation (ESO) guideline on screening for subclinical atrial fibrillation after stroke or transient ischaemic attack of undetermined origin 140
Exploring Sex Differences in Outcomes of Dual Antiplatelet Therapy for Patients With Noncardioembolic Mild-to-Moderate Ischemic Stroke or High-Risk Transient Ischemic Attack: A Propensity-Matched Analysis of the READAPT Study Cohort 135
15-Year Outcomes of PFO Closure in Patients With Cryptogenic Embolism: Insights From the PROLONG Registry 134
Early seizures and risk of epilepsy and death after intracerebral haemorrhage: The MUCH Italy 133
Volume Tolerance and Prognostic Impact of Hematoma Expansion in Deep and Lobar Intracerebral Hemorrhage 128
Admission systolic blood pressure and short-term outcomes after dual antiplatelet therapy in patients with minor ischemic stroke or transient ischemic attack 120
Combining Intravenous Thrombolysis and Dual Antiplatelet Treatment in Patients With Minor Ischemic Stroke: A Propensity Matched Analysis of the READAPT Study Cohort 119
Age- and sex-specific analysis of patients with embolic stroke of undetermined source 115
Real-world comparison of dual versus single antiplatelet treatment in patients with non-cardioembolic mild-to-moderate ischemic stroke: A propensity matched analysis 108
Net Benefit of Early Anticoagulation for Stroke With Atrial Fibrillation: Post Hoc Analysis of the ELAN Randomized Clinical Trial 107
Practical "1-2-3-4-Day" Rule for Starting Direct Oral Anticoagulants After Ischemic Stroke With Atrial Fibrillation: Combined Hospital-Based Cohort Study 105
Long-term outcome of cervical artery dissection : IPSYS CeAD: study protocol, rationale, and baseline data of an Italian multicenter research collaboration 105
Long-Term Risk of Arterial Thrombosis After Intracerebral Hemorrhage: MUCH-Italy 103
Acute myocardial infarction and heart failure in acute stroke patients: frequency and influence on clinical outcome 101
Antithrombotic therapy in the postacute phase of cervical artery dissection: the Italian Project on Stroke in Young Adults Cervical Artery Dissection 100
Un caffè tra due amici al bar. L'esame obiettivo neurologico 99
Treatments in Ischemic Stroke: Current and Future 99
Statin use and long-term risk of recurrent intracerebral haemorrhage: the MUCH-Italy 99
Early Versus Late Initiation of Direct Oral Anticoagulants After Ischemic Stroke in People With Atrial Fibrillation and Hemorrhagic Transformation: Prespecified Subanalysis of the Randomized Controlled ELAN Trial 97
Effectiveness and safety of dual antiplatelet therapy in patients with minor ischemic stroke or transient ischemic attack and cancer: A secondary analysis of the READAPT study 97
Intravenous thrombolysis in patients with acute ischaemic stroke and active cancer (the ITACA-stroke study) 97
Beyond RCTs: Short-term dual antiplatelet therapy in secondary prevention of ischemic stroke and transient ischemic attack 97
Real-World Dual Antiplatelet Therapy Use Exceeds Randomized Trials Boundaries With Possible Safety Issues in Patients With Large Artery Atherosclerosis-Insights From the READAPT Study 95
Early versus late start of direct oral anticoagulants after acute ischaemic stroke linked to atrial fibrillation: an observational study and individual patient data pooled analysis 95
Thrombolysis after dabigatran reversal: A nation-wide Italian multicentre study, systematic review and meta-analysis 94
Safety and efficacy of concomitant treatment with non-vitamin K antagonist oral anticoagulants and antiseizure medications: A propensity score matching cohort study 94
Risk Profile of Patients with Spontaneous Cervical Artery Dissection 93
A tool to identify patients with embolic stroke of undetermined source at high recurrence risk 93
History of stroke 92
Predictors of Recurrent Venous Thrombosis After Cerebral Venous Thrombosis: Analysis of the ACTION-CVT Study 89
Clinical Features of Patients With Cervical Artery Dissection and Fibromuscular Dysplasia 88
Long-Term Risk of Recurrent Cervical Artery Dissection and Stroke After Pregnancy 88
Acute hyperglycemia and early hemorrhagic transformation in ischemic stroke 88
Risk of Recurrent Stroke, Mortality, and Intracerebral Hemorrhage in Patients With Atrial Fibrillation Detected Before or After a Stroke 87
Medical versus neurosurgical treatment in ICH patients: a single center experience 87
Anticoagulation in acute ischemic stroke patients with mechanical heart valves: To bridge or not with heparin. The ESTREM study 87
Admission Leukocytosis in Acute Cerebral Ischemia: Influence on Early Outcome 86
Secondary stroke prevention in people with atrial fibrillation: treatments and trials 85
Outcomes and Recurrence Rates Among Patients With Provoked and Cryptogenic Cerebral Venous Thrombosis: Analysis of the ACTION CVT 83
History of cardiac embolism 83
Outcome Prediction in Cerebral Venous Thrombosis: The IN-REvASC Score 82
Anticoagulant vs. antiplatelet therapy in patients with cryptogenic stroke and patent foramen ovale: an individual participant dta meta-analysis 82
Consensus paper on the management of acute isolated vertigo in the emergency department 82
Characteristics and causes of recurrent ischemic events in minor ischemic stroke and TIA in the READAPT study 81
Age-dependent effect of susceptibility factors on the risk of intracerebral haemorrhage: Multicenter Study on Cerebral Hemorrhage in Italy (MUCH-Italy) 80
A nomogram to predict unfavourable outcome in patients receiving oral anticoagulants for atrial fibrillation after stroke 80
Early versus Later Anticoagulation for Stroke with Atrial Fibrillation 80
Stroke network performance during the first COVID-19 pandemic stage: A meta-analysis based on stroke network models 79
Divergence Between Clinical Trial Evidence and Actual Practice in Use of Dual Antiplatelet Therapy After Transient Ischemic Attack and Minor Stroke 79
Functional outcome improvement from 3 to 12 months after intracerebral hemorrhage 78
Timing of oral anticoagulants initiation for atrial fibrillation after acute ischemic stroke: A systematic review and meta-analysis 78
Timing and Predictors of Recanalization After Anticoagulation in Cerebral Venous Thrombosis 77
Comparative study of venous thromboembolic prophylaxis strategies in hemorrhagic stroke: A systematic review and network meta-analysis 77
Early versus Late initiation of direct oral Anticoagulants in post-ischaemic stroke patients with atrial fibrillatioN (ELAN): Protocol for an international, multicentre, randomised-controlled, two-arm, open, assessor-blinded trial 76
96 hours ECGmonitoring for patients with ischemic cryptogenic stroke or transient ischaemicattack 76
Sex-related differences in clinical characteristics, treatment and outcomes in patients with atrial fibrillation and acute ischemic stroke treated with non-vitamin-K antagonists 76
Characteristics of intracerebral hemorrhage associated with dual antiplatelet treatment 76
Recurrent Ischemic Stroke and Bleeding in Patients With Atrial Fibrillation Who Suffered an Acute Stroke While on Treatment With Nonvitamin K Antagonist Oral Anticoagulants: The RENO-EXTEND Study 75
Prevalence of patent foramen ovale in ischemic stroke in Italy: the SISIFO study 74
Predictors of severe intracerebral hemorrhage expansion 73
The turning point in stroke investigation for neurologists 72
Anticoagulation Strategies Following Breakthrough Ischemic Stroke While on Direct Anticoagulants: A Meta-Analysis 72
Hypertension, seizures, and epilepsy: a review on pathophysiology and management 72
Real-world outcomes following dual antiplatelet therapy in mild-to-moderate ischemic stroke with anterior versus posterior circulation infarct: a READAPT study propensity matched analysis 72
Anticoagulation After Stroke in Patients With Atrial Fibrillation 72
Pure sensory syndromes in thalamic stroke 71
Prolonged cardiac monitoring for stroke prevention: A systematic review and meta-analysis of randomized-controlled clinical trials 71
Reperfusion therapies in patients with acute ischaemic stroke and atrial fibrillation: data on safety and effectiveness from a multi-centre cohort study 71
Hypercoagulability State in Predicting Severe Functional Outcome in Patients with Acute Ischemic Stroke: Cause, Consequence, or Both? 70
Effects of Direct Oral Anticoagulants' Nonrecommended Dose in Atrial Fibrillation: A Meta-Analysis 70
Defining short-term outcomes of minor ischemic stroke due to small artery occlusion in the era of dual antiplatelet treatment: A READAPT study sub-analysis 69
Ischemic stroke while on NOAC therapy in patients with atrial fibrillation: suggested treatment strategies 68
A case of typical headache with an atypical diagnosis 67
Migraine improvement after spontaneous cervical artery dissection the Italian Project on Stroke in Young Adults (IPSYS) 67
The Impact of Atherosclerotic Burden on Vascular Outcomes in Patients with Stroke and Atrial Fibrillation: The ATHENA study 66
The risk of stroke recurrence in patients with atrial fibrillation and reduced ejection fraction 66
Acute stroke symptoms: Do differences exist between sexes? 65
A sudden neurological deficit in a patient with endocarditis 65
Alcohol intake and the risk of intracerebral hemorrhage in the elderly: The MUCH-Italy 65
The clinical spectrum of reversible cerebral vasoconstriction syndrome: The Italian Project on Stroke at Young Age (IPSYS) 65
Migraine and Cryptogenic Ischemic Stroke 64
Investigational drugs for ischemic stroke: what's in the clinical development pipeline for acute phase and prevention? 64
Prevention of venous thromboembolism in acute spontaneous intracerebral haemorrhage: A survey of opinion 64
Profilassi secondaria nel paziente con attacco ischemico transitorio o ictus aterotrombotico carotideo [Secondary prevention in patients with transient ischemic attack or stroke due to carotid atherosclerosis] 63
Acute hematoma expansion after spontaneous intracerebral hemorrhage: risk factors and impact on long-term prognosis 63
The concept of ischemic penumbra in acute stroke and therapeutic opportunities 63
[Multidisciplinary position paper on the management of patent foramen ovale in the presence of cryptogenic cerebral ischemia - Italian version 2013] 62
The Perugia hospital-based Stroke Registry: report of the 2nd year 60
Angiographic findings of moyamoya vessels in a patient with rheumatoid arthritis 60
Erratum to: Prevalence of patent foramen ovale in ischemic stroke in Italy: the SISIFO Study (Neurol Sci (2014) 35, (867-873), 10.1007/s10072-013-1615-2) 60
Misidentifications in Pirandello's plays and short stories 59
Location and Timing of Recurrent, Nontraumatic Intracerebral Hemorrhage 59
Semeiotica e gestione delle urgenze neurologiche 59
Totale 10.012
Categoria #
all - tutte 58.628
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.796
Totale 62.424


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212 0 0 0 0 0 0 0 0 0 0 0 2
2021/202218 2 1 0 5 1 0 3 0 0 0 2 4
2022/20238 2 1 0 0 0 0 1 0 1 2 0 1
2023/20246 1 0 0 0 1 0 0 0 0 0 0 4
2024/20252.068 0 0 4 0 2 78 395 315 224 524 271 255
2025/202613.855 571 675 1.161 1.559 1.337 480 789 616 1.055 1.611 1.988 2.013
Totale 16.020